@prefix dc: .
@prefix this: .
@prefix sub: .
@prefix beldoc: .
@prefix rdfs: .
@prefix rdf: .
@prefix xsd: .
@prefix dce: .
@prefix pav: .
@prefix np: .
@prefix belv: .
@prefix prov: .
@prefix schem: .
@prefix go: .
@prefix Protein: .
@prefix rgd: .
@prefix geneProductOf: .
@prefix hasAgent: .
@prefix hasAnnotation: .
@prefix species: .
@prefix occursIn: .
@prefix mesh: .
@prefix atcc: .
@prefix pubmed: .
@prefix orcid: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
sub:_1 hasAgent: sub:_2;
a go:0003824 .
sub:_2 geneProductOf: rgd:1549703;
a Protein: .
sub:_3 occursIn: mesh:D007515, atcc:CRL-2057.aspx, species:10116;
hasAnnotation: sub:_4;
rdf:object sub:_1;
rdf:predicate belv:directlyDecreases;
rdf:subject schem:Azaserine;
a rdf:Statement .
sub:_4 dc:subject "TextLocation";
rdf:value "Results" .
sub:assertion rdfs:label "a(SCHEM:Azaserine) =| cat(p(RGD:Gfpt1))" .
}
sub:provenance {
beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds.";
dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved.";
dce:title "BEL Framework Small Corpus Document";
dc:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License";
pav:authoredBy sub:_6;
pav:version "1.6" .
sub:_5 prov:value """Inhibition of hexosamine biosynthesis by the GFAT inhibitor azaserine reversed the
stimulatory effects of glucose on JNK, c-Jun, and ERK1/2 activation (Fig. 9, A–C)
as well as IRS-1 phosphorylation at Ser307 and Ser612 (Fig. 10, A and B).""";
prov:wasQuotedFrom pubmed:15001544 .
sub:_6 rdfs:comment "support@belframework.org";
rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:15001544;
prov:wasDerivedFrom beldoc:, sub:_5 .
}
sub:pubinfo {
this: dc:created "2014-07-03T14:29:33.084+02:00"^^xsd:dateTime;
pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}